Geron Corp (GERN)

[Charleston]

To ignore the possibility of 2018 FDA approval is missing due diligence. A drug with Fast Track Designation can be approved for NDA if the drug fulfills an unmet need or shows improved efficacy over the existing treatment. Imetelstat does both. This can be approved after the phase 2 study that just ended. Janssen is a beast that knows how to bring drugs to market with utmost discretion.